• Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023

    来源: Nasdaq GlobeNewswire / 01 11月 2023 07:00:00   America/New_York

    PRINCETON, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November.

    • UBS Biopharma Conference in Miami, FL on Thursday, November 9, 2023, at 1:00 p.m. E.T.
    • Stifel 2023 Healthcare Conference in New York, NY on Wednesday, November 15, 2023, at 8:00 a.m. E.T.

    A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

    About Amicus Therapeutics
    Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.

    CONTACT:

    Investors:
    Amicus Therapeutics
    Andrew Faughnan
    Vice President, Investor Relations
    afaughnan@amicusrx.com
    (609) 662-3809

    Media:
    Amicus Therapeutics
    Diana Moore
    Head of Global Corporate Communications
    dmoore@amicusrx.com
    (609) 662-5079

    FOLD–G


    Primary Logo

分享